Skip to content

Optimal Management of Vasa Previa Study - A Retrospective Study

Optimal Management of Vasa Previa: Screening, Diagnosis and Management - A Retrospective Study.

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01977040
Acronym
VasaPrevia
Enrollment
68
Registered
2013-11-06
Start date
2014-01-31
Completion date
2015-01-31
Last updated
2019-01-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Vasa Previa

Keywords

Vasa Previa

Brief summary

This is a multicenter retrospective observational study of women diagnosed with a vasa previa during pregnancy or at delivery who delivered between 2000 and 2012. The study hopes to be able to describe techniques utilized to screen for and diagnose vasa previa as well as to describe the maternal characteristics and identify potential underlying risk factors that may provide a basis for future screening recommendations for vasa previa and treatment protocols.

Detailed description

This is a multicenter retrospective study of women identified as having a vasa previa during pregnancy or at the time of delivery who delivered between January 1, 2000 and December 31, 2012 at participating centers. The primary objective of the study is to describe techniques utilized to screen for and diagnose vasa previa. * In those cases that were diagnosed antenatally, to describe the different management protocols utilized, correlate these management protocols with neonatal outcomes and support the management protocol that offers optimal outcomes for both mother and neonate. * In those cases that were not diagnosed antenatally, to describe the clinical scenario surrounding delivery and the neonatal outcomes. Review the ultrasound reports and maternal characteristics to identify any potential risk factors for vasa previa that could have been identified antenatally in attempt to improve neonatal outcomes in the future. * In all cases of diagnosed vasa previa (those diagnosed antepartum, intrapartum, and postpartum), to describe the maternal characteristics and identify potential underlying risk factors that may provide a basis for future screening recommendations and protocols. Due to the rarity of this diagnosis, the study hopes to include 100-250 participants.

Interventions

None listed

Sponsors

Obstetrix Medical Group
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Healthy volunteers
Yes

Inclusion criteria

* Patients with the diagnosed of vasa previa made either during the pregnancy via ultrasound or at time of delivery via clinical and/or pathologic investigation. * Patient delivered between January 2000 through December 2012

Exclusion criteria

* No diagnosis or confirmation of vasa previa * Delivered either before January 1, 2000 or after December 31, 2012

Design outcomes

Primary

MeasureTime frameDescription
Diagnostic Profile of Techniques Utilized to Screen for and Diagnose Vasa Previa During Pregnancy.Participants will be followed from time of diagnosis of vasa previa until the baby is born, an expected time frame of 9 monthsThe primary outcome of the study it to describe antenatal techniques utilized to screen for and diagnose vasa previa. Vasa previa is when unprotected blood vessels implanted in the membranes or sac run from the placenta across the inside of the woman's cervix. Antepartum ultrasounds were conducted according to standard of care. Here we report the count of participants who were diagnosed during routine ultrasound exam. After initial diagnosis by ultrasound, Vasa Previa's were followed up by routine ultrasounds for confirmation prior to delivery.
Gestational Age at Time of Diagnosis Stratified by Diagnostic Profile.Participants will be followed from time of diagnosis of vasa previa during the second trimester up until delivery.
Mode of Delivery Stratified by Diagnostic Profile.At birth.Mode of delivery (C/S - emergent, non-emergent, vaginal) stratified by diagnostic profile
Gestational Age of Infant at BirthAt birth.Gestational age of the infant noted in weeks at the time of birth

Countries

United States

Participant flow

Recruitment details

In a retrospective manner, we recruited all pregnancies complicated by vasa previa that delivery between January 1, 2000 and December 31, 2012 at nine Maternal Fetal Medicine Practices. The diagnosis of vasa previa was made either during the antenatal period by an ultrasound or at the time of delivery via clinical and/or pathologic investigation

Participants by arm

ArmCount
Vasa Previa
Women with the diagnosis of Vasa Previa made during the pregnancy or at time of delivery who delivered between January 1, 2000 and December 31, 2012.
68
Total68

Withdrawals & dropouts

PeriodReasonFG000
Overall StudyVasa previa not confirmed2

Baseline characteristics

CharacteristicVasa Previa
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
0 Participants
Age, Categorical
Between 18 and 65 years
68 Participants
Region of Enrollment
United States
68 participants
Sex: Female, Male
Female
68 Participants
Sex: Female, Male
Male
0 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 0
other
Total, other adverse events
0 / 0
serious
Total, serious adverse events
0 / 0

Outcome results

Primary

Diagnostic Profile of Techniques Utilized to Screen for and Diagnose Vasa Previa During Pregnancy.

The primary outcome of the study it to describe antenatal techniques utilized to screen for and diagnose vasa previa. Vasa previa is when unprotected blood vessels implanted in the membranes or sac run from the placenta across the inside of the woman's cervix. Antepartum ultrasounds were conducted according to standard of care. Here we report the count of participants who were diagnosed during routine ultrasound exam. After initial diagnosis by ultrasound, Vasa Previa's were followed up by routine ultrasounds for confirmation prior to delivery.

Time frame: Participants will be followed from time of diagnosis of vasa previa until the baby is born, an expected time frame of 9 months

ArmMeasureGroupValue (COUNT_OF_PARTICIPANTS)
Vasa PreviaDiagnostic Profile of Techniques Utilized to Screen for and Diagnose Vasa Previa During Pregnancy.No antepartum diagnosis, Vasa Previa at birth2 Participants
Vasa PreviaDiagnostic Profile of Techniques Utilized to Screen for and Diagnose Vasa Previa During Pregnancy.Antepartum Ultrasound, confirmed at delivery47 Participants
Vasa PreviaDiagnostic Profile of Techniques Utilized to Screen for and Diagnose Vasa Previa During Pregnancy.Antepartum Ultrasound, not confirmed at delivery13 Participants
Vasa PreviaDiagnostic Profile of Techniques Utilized to Screen for and Diagnose Vasa Previa During Pregnancy.Antepartum Ultrasound, resolved prior to delivery4 Participants
Primary

Gestational Age at Time of Diagnosis Stratified by Diagnostic Profile.

Time frame: Participants will be followed from time of diagnosis of vasa previa during the second trimester up until delivery.

Population: Only 64 participants had vasa previa diagnosed via ultrasound during the antenatal period.

ArmMeasureGroupValue (MEAN)
Vasa PreviaGestational Age at Time of Diagnosis Stratified by Diagnostic Profile.Antepartum Ultrasound, confirmed at delivery27.0 weeks
Vasa PreviaGestational Age at Time of Diagnosis Stratified by Diagnostic Profile.Antepartum Ultrasound, not confirmed at delivery27.8 weeks
Vasa PreviaGestational Age at Time of Diagnosis Stratified by Diagnostic Profile.Antepartum Ultrasound, resolved prior to delivery19.8 weeks
Primary

Gestational Age of Infant at Birth

Gestational age of the infant noted in weeks at the time of birth

Time frame: At birth.

Population: Mean Gestational age at delivery as well as Mean Gestational Age for those patients who delivered emergently and non-emergent are presented.

ArmMeasureGroupValue (MEAN)Dispersion
Vasa PreviaGestational Age of Infant at BirthAntepartum Ultrasound, not confirmed at delivery31.50 weeksStandard Deviation 2.73
Vasa PreviaGestational Age of Infant at BirthNo antepartum diagnosis, Vasa Previa at birth36.14 weeksStandard Deviation 1
Vasa PreviaGestational Age of Infant at BirthAntepartum Ultrasound, confirmed at delivery34.76 weeksStandard Deviation 1.24
Non-Emergent Cesarean SectionGestational Age of Infant at BirthNo antepartum diagnosis, Vasa Previa at birth35.57 weeksStandard Deviation 0.4
Non-Emergent Cesarean SectionGestational Age of Infant at BirthAntepartum Ultrasound, not confirmed at delivery34.78 weeksStandard Deviation 1.47
Non-Emergent Cesarean SectionGestational Age of Infant at BirthAntepartum Ultrasound, confirmed at delivery34.68 weeksStandard Deviation 1.84
Non-Emergent Cesarean SectionGestational Age of Infant at BirthAntepartum Ultrasound, resolved prior to delivery37.04 weeksStandard Deviation 1.55
Primary

Mode of Delivery Stratified by Diagnostic Profile.

Mode of delivery (C/S - emergent, non-emergent, vaginal) stratified by diagnostic profile

Time frame: At birth.

ArmMeasureGroupValue (COUNT_OF_PARTICIPANTS)
Vasa PreviaMode of Delivery Stratified by Diagnostic Profile.Antepartum Ultrasound, confirmed at delivery7 Participants
Vasa PreviaMode of Delivery Stratified by Diagnostic Profile.Antepartum Ultrasound, not confirmed at delivery2 Participants
Vasa PreviaMode of Delivery Stratified by Diagnostic Profile.Antepartum Ultrasound, resolved prior to delivery0 Participants
Vasa PreviaMode of Delivery Stratified by Diagnostic Profile.No antepartum diagnosis, Vasa Previa at birth1 Participants
Non-Emergent Cesarean SectionMode of Delivery Stratified by Diagnostic Profile.No antepartum diagnosis, Vasa Previa at birth1 Participants
Non-Emergent Cesarean SectionMode of Delivery Stratified by Diagnostic Profile.Antepartum Ultrasound, confirmed at delivery40 Participants
Non-Emergent Cesarean SectionMode of Delivery Stratified by Diagnostic Profile.Antepartum Ultrasound, resolved prior to delivery1 Participants
Non-Emergent Cesarean SectionMode of Delivery Stratified by Diagnostic Profile.Antepartum Ultrasound, not confirmed at delivery9 Participants
Vaginal DeliveryMode of Delivery Stratified by Diagnostic Profile.No antepartum diagnosis, Vasa Previa at birth0 Participants
Vaginal DeliveryMode of Delivery Stratified by Diagnostic Profile.Antepartum Ultrasound, not confirmed at delivery2 Participants
Vaginal DeliveryMode of Delivery Stratified by Diagnostic Profile.Antepartum Ultrasound, resolved prior to delivery1 Participants
Vaginal DeliveryMode of Delivery Stratified by Diagnostic Profile.Antepartum Ultrasound, confirmed at delivery2 Participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026